​

Funding Round

Post-IPO Equity - Harpoon Therapeutics

Post-IPO Equity - Harpoon Therapeutics

Investment Firm

Overview

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Announced Date

Oct 23, 2023

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

9

Investor Name
Participant InvestorAlly Bridge Group
Participant InvestorK2 HealthVentures
Participant InvestorRA Capital Management
Participant InvestorNew Leaf Venture Partners
Participant InvestorInvus

Round Details and Background

Harpoon Therapeutics raised $100000000 on 2023-10-23 in Post-IPO Equity

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 23, 2023
Post-IPO Equity - Harpoon Therapeutics
10-100.0M
Mar 27, 2023
Post-IPO Equity - Harpoon Therapeutics
5-25.0M
May 25, 2017
Series B - Harpoon Therapeutics
5-45.0M
Apr 01, 2016
Series A - Harpoon Therapeutics
2-15.0M

Recent Activity

There is no recent news or activity for this profile.